The ability of Sox2 to promote castration-resistant tumor growth of AR-dependent LAPC-4 prostate cancer cells without impacting CD133 or PSA expression suggested that Sox2 does not promote the re-expression of embryonic stem cell genes thereby promoting a “stemness” phenotype similar to that observed in tumor initiating/stem cells. Here, AR is linked to prostate cancer.